Artivion Receives US FDA Approval for AMDS Hybrid...
Category : Approval/Launch 1 July 2026FDA Approves Artivion's AMDS Hybrid Prosthesis Artivion, Inc. has received premarket approval...
Newsletter - All News
Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research
Sanofi Reports Positive Phase 3 Results for Nexvia...
Category : Clinical Trial Update 1 July 2026Phase 3 Study Meets Primary and Secondary Endpoints Sanofi has announced positive topline results...
Alembic Pharmaceuticals Receives US FDA Approval f...
Category : Approval/Launch 30 June 2026Alembic Expands Its US Generic Portfolio Alembic Pharmaceuticals Limited has received...
NeuroSense Reports Positive Phase 2b Results for P...
Category : Clinical Trial Update 30 June 2026PrimeC Achieves Primary Goal in Phase 2b ALS Trial NeuroSense Therapeutics has announ...
Alembic Pharma Receives US FDA Approval for Generi...
Category : Approval/Launch 29 June 2026Alembic Pharmaceuticals Limited has received final approval from the U.S. Food and Drug Administrati...
Latest Newsletter Post
-
Sanofi Reports Positive Phase 3 Res..
1 July 2026
-
Artivion Receives US FDA Approval f..
1 July 2026
-
NeuroSense Reports Positive Phase 2..
30 June 2026
-
Alembic Pharmaceuticals Receives US..
30 June 2026
-
BridgeBio Publishes Positive Phase..
29 June 2026
